Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats
- PMID: 18058807
- DOI: 10.1002/mc.20403
Interrelationships between dietary restriction, the IGF-I axis, and expression of vascular endothelial growth factor by prostate adenocarcinoma in rats
Abstract
Human studies suggest that excessive energy intake and obesity may influence prostate cancer progression. Rodent experiments demonstrate that diet restriction attenuates tumor growth in parallel with reduced vascular density. The present study examines changes in the insulin-like growth factor I (IGF-I) axis caused by dietary restriction and their association with the expression of vascular endothelial growth factor (VEGF) in prostate cancer. Weanling male Copenhagen rats were randomized into control or 40% dietary restricted groups (n = 5). After 8 wk, rats were implanted with rat AT6.3 prostate adenocarcinoma cells. Two weeks later, the animals were sacrificed and serum, normal prostate, liver, and prostate tumor samples were collected for analyses. Dietary restriction reduced serum concentrations of IGF-I by 35% (P < 0.05) and increased IGF-binding protein-3 (IGFBP3) by sevenfold (P < 0.0001). Lower circulating IGF-I concentrations were correlated with reduced IGF-I mRNA expression in the liver, the primary source of circulating IGF-I. Dietary restriction also lowered mRNA expression of IGF-I (45%, P = 0.0242) and its receptor IGFIR (40%, P = 0.0083) in prostate tumors. Similarly, reduced VEGF mRNA (30%, P = 0.0176) and secreted VEGF protein (33%, P = 0.0003) were observed in prostate cancer of restricted rats. An in vitro study employing AT6.3 prostate cancer cells demonstrated dose- and time-dependent stimulation of VEGF expression by IGF-I. These results suggest that dietary restriction reduces endocrine and prostate tumor autocrine/paracrine IGF-I expression, which contributes to reduced VEGF expression and signaling, to inhibit tumor angiogenesis associated with prostate tumorigenesis.
(c) 2007 Wiley-Liss, Inc.
Similar articles
-
The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.Cancer Res. 1999 May 1;59(9):2203-9. Cancer Res. 1999. PMID: 10232609
-
Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.J Nutr Biochem. 2007 Jun;18(6):408-17. doi: 10.1016/j.jnutbio.2006.08.006. Epub 2006 Dec 4. J Nutr Biochem. 2007. PMID: 17142033
-
Inhibition of proliferation of PC-3 human prostate cancer by antagonists of growth hormone-releasing hormone: lack of correlation with the levels of serum IGF-I and expression of tumoral IGF-II and vascular endothelial growth factor.Prostate. 2002 Aug 1;52(3):173-82. doi: 10.1002/pros.10105. Prostate. 2002. PMID: 12111694
-
Roles for insulin-like growth factor-1 in mediating the anti-carcinogenic effects of caloric restriction.J Nutr Health Aging. 1999;3(2):92-101. J Nutr Health Aging. 1999. PMID: 10885804 Review.
-
Energy balance, physical activity, and cancer risk.Methods Mol Biol. 2009;472:57-88. doi: 10.1007/978-1-60327-492-0_3. Methods Mol Biol. 2009. PMID: 19107429 Review.
Cited by
-
Dietary Interventions in Cancer Treatment and Response: A Comprehensive Review.Cancers (Basel). 2022 Oct 20;14(20):5149. doi: 10.3390/cancers14205149. Cancers (Basel). 2022. PMID: 36291933 Free PMC article. Review.
-
Sex Differences in Metabolic Recuperation After Weight Loss in High Fat Diet-Induced Obese Mice.Front Endocrinol (Lausanne). 2021 Dec 16;12:796661. doi: 10.3389/fendo.2021.796661. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34975768 Free PMC article.
-
FOXP1 and NDRG1 act differentially as downstream effectors of RAD9-mediated prostate cancer cell functions.Cell Signal. 2021 Oct;86:110091. doi: 10.1016/j.cellsig.2021.110091. Epub 2021 Jul 21. Cell Signal. 2021. PMID: 34298089 Free PMC article.
-
Understanding the complex role of mTORC as an intracellular critical mediator of whole-body metabolism in anorexia nervosa: A mini review.Acta Biomed. 2021 Feb 18;92(1):e2021170. doi: 10.23750/abm.v92i1.11342. Acta Biomed. 2021. PMID: 33682848 Free PMC article. Review.
-
Randomized trial evaluating the role of weight loss in overweight and obese men with early stage prostate Cancer on active surveillance: Rationale and design of the Prostate Cancer Active Lifestyle Study (PALS).Contemp Clin Trials. 2019 Jun;81:34-39. doi: 10.1016/j.cct.2019.04.004. Epub 2019 Apr 16. Contemp Clin Trials. 2019. PMID: 31002955 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
